Outcomes for medicaid clients with substance abuse problems before and after managed care

Bentson McFarland, Dennis D. Deck, Lynn E. McCamant, Roy M. Gabriel, Douglas A. Bigelow

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Medicaid conversion from fee for service to managed care raised numerous questions about outcomes for substance abuse treatment clients. For example, managed care criticisms include concerns that clients will be undertreated (with too short and/or insufficiently intense services). Also of interest are potential variations in outcome for clients served by organizations with assorted financial arrangements such as for-profit status versus not-for-profit status. In addition, little information is available about the impact of state Medicaid managed care policies (including client eligibility) on treatment outcomes. Subjects of this project were Medicaid clients aged 18-64 years enrolled in the Oregon Health Plan during 1994 (before substance abuse treatment managed care, N = 1751) or 1996-1997 (after managed care, N = 14,813), who were admitted to outpatient non-methadone chemical dependency treatment services. Outcome measures were retention in treatment for 90 days or more, completion of a treatment program, abstinence at discharge, and readmission to treatment. With the exception of readmission, there were no notable differences in outcomes between the fee for service era clients versus those in capitated chemical dependency treatment. There were at most minor differences among various managed care systems (such as for-profit vs not-for-profit). However, duration of Medicaid eligibility was a powerful predictor of positive outcomes. Medicaid managed care does not appear to have had an adverse impact on outcomes for clients with substance abuse problems. On the other hand, state policies influencing Medicaid enrollment may have substantial impact on chemical dependency treatment outcomes.

Original languageEnglish (US)
Pages (from-to)351-367
Number of pages17
JournalJournal of Behavioral Health Services and Research
Volume32
Issue number4
DOIs
StatePublished - Oct 2005

Fingerprint

Medicaid
Managed Care Programs
managed care
substance abuse
Substance-Related Disorders
chemical dependency
profit
Fee-for-Service Plans
fee
Therapeutics
available information
Outpatients
criticism
Outcome Assessment (Health Care)
Organizations
Health
health
Dependency (Psychology)

ASJC Scopus subject areas

  • Health(social science)
  • Health Professions(all)

Cite this

Outcomes for medicaid clients with substance abuse problems before and after managed care. / McFarland, Bentson; Deck, Dennis D.; McCamant, Lynn E.; Gabriel, Roy M.; Bigelow, Douglas A.

In: Journal of Behavioral Health Services and Research, Vol. 32, No. 4, 10.2005, p. 351-367.

Research output: Contribution to journalArticle

McFarland, Bentson ; Deck, Dennis D. ; McCamant, Lynn E. ; Gabriel, Roy M. ; Bigelow, Douglas A. / Outcomes for medicaid clients with substance abuse problems before and after managed care. In: Journal of Behavioral Health Services and Research. 2005 ; Vol. 32, No. 4. pp. 351-367.
@article{3815f7e288934c858c4eef26776d4c21,
title = "Outcomes for medicaid clients with substance abuse problems before and after managed care",
abstract = "Medicaid conversion from fee for service to managed care raised numerous questions about outcomes for substance abuse treatment clients. For example, managed care criticisms include concerns that clients will be undertreated (with too short and/or insufficiently intense services). Also of interest are potential variations in outcome for clients served by organizations with assorted financial arrangements such as for-profit status versus not-for-profit status. In addition, little information is available about the impact of state Medicaid managed care policies (including client eligibility) on treatment outcomes. Subjects of this project were Medicaid clients aged 18-64 years enrolled in the Oregon Health Plan during 1994 (before substance abuse treatment managed care, N = 1751) or 1996-1997 (after managed care, N = 14,813), who were admitted to outpatient non-methadone chemical dependency treatment services. Outcome measures were retention in treatment for 90 days or more, completion of a treatment program, abstinence at discharge, and readmission to treatment. With the exception of readmission, there were no notable differences in outcomes between the fee for service era clients versus those in capitated chemical dependency treatment. There were at most minor differences among various managed care systems (such as for-profit vs not-for-profit). However, duration of Medicaid eligibility was a powerful predictor of positive outcomes. Medicaid managed care does not appear to have had an adverse impact on outcomes for clients with substance abuse problems. On the other hand, state policies influencing Medicaid enrollment may have substantial impact on chemical dependency treatment outcomes.",
author = "Bentson McFarland and Deck, {Dennis D.} and McCamant, {Lynn E.} and Gabriel, {Roy M.} and Bigelow, {Douglas A.}",
year = "2005",
month = "10",
doi = "10.1007/BF02384196",
language = "English (US)",
volume = "32",
pages = "351--367",
journal = "Journal of Behavioral Health Services and Research",
issn = "1094-3412",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Outcomes for medicaid clients with substance abuse problems before and after managed care

AU - McFarland, Bentson

AU - Deck, Dennis D.

AU - McCamant, Lynn E.

AU - Gabriel, Roy M.

AU - Bigelow, Douglas A.

PY - 2005/10

Y1 - 2005/10

N2 - Medicaid conversion from fee for service to managed care raised numerous questions about outcomes for substance abuse treatment clients. For example, managed care criticisms include concerns that clients will be undertreated (with too short and/or insufficiently intense services). Also of interest are potential variations in outcome for clients served by organizations with assorted financial arrangements such as for-profit status versus not-for-profit status. In addition, little information is available about the impact of state Medicaid managed care policies (including client eligibility) on treatment outcomes. Subjects of this project were Medicaid clients aged 18-64 years enrolled in the Oregon Health Plan during 1994 (before substance abuse treatment managed care, N = 1751) or 1996-1997 (after managed care, N = 14,813), who were admitted to outpatient non-methadone chemical dependency treatment services. Outcome measures were retention in treatment for 90 days or more, completion of a treatment program, abstinence at discharge, and readmission to treatment. With the exception of readmission, there were no notable differences in outcomes between the fee for service era clients versus those in capitated chemical dependency treatment. There were at most minor differences among various managed care systems (such as for-profit vs not-for-profit). However, duration of Medicaid eligibility was a powerful predictor of positive outcomes. Medicaid managed care does not appear to have had an adverse impact on outcomes for clients with substance abuse problems. On the other hand, state policies influencing Medicaid enrollment may have substantial impact on chemical dependency treatment outcomes.

AB - Medicaid conversion from fee for service to managed care raised numerous questions about outcomes for substance abuse treatment clients. For example, managed care criticisms include concerns that clients will be undertreated (with too short and/or insufficiently intense services). Also of interest are potential variations in outcome for clients served by organizations with assorted financial arrangements such as for-profit status versus not-for-profit status. In addition, little information is available about the impact of state Medicaid managed care policies (including client eligibility) on treatment outcomes. Subjects of this project were Medicaid clients aged 18-64 years enrolled in the Oregon Health Plan during 1994 (before substance abuse treatment managed care, N = 1751) or 1996-1997 (after managed care, N = 14,813), who were admitted to outpatient non-methadone chemical dependency treatment services. Outcome measures were retention in treatment for 90 days or more, completion of a treatment program, abstinence at discharge, and readmission to treatment. With the exception of readmission, there were no notable differences in outcomes between the fee for service era clients versus those in capitated chemical dependency treatment. There were at most minor differences among various managed care systems (such as for-profit vs not-for-profit). However, duration of Medicaid eligibility was a powerful predictor of positive outcomes. Medicaid managed care does not appear to have had an adverse impact on outcomes for clients with substance abuse problems. On the other hand, state policies influencing Medicaid enrollment may have substantial impact on chemical dependency treatment outcomes.

UR - http://www.scopus.com/inward/record.url?scp=32044435645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32044435645&partnerID=8YFLogxK

U2 - 10.1007/BF02384196

DO - 10.1007/BF02384196

M3 - Article

C2 - 16215446

AN - SCOPUS:32044435645

VL - 32

SP - 351

EP - 367

JO - Journal of Behavioral Health Services and Research

JF - Journal of Behavioral Health Services and Research

SN - 1094-3412

IS - 4

ER -